"InterVenn's colorectal cancer assay is not meant as a...

"InterVenn's colorectal cancer assay is not meant as a population screening tool but rather is intended for use in patients considered at high risk for the disease. The test aims to detect advanced adenomas, which can turn into colorectal cancers if left untreated."

In other words, their test is expensive.

They already have two other 'groundbreaking' cancer tests (lung and cervical) that they have put on the back burner...hmmmm

https://www.360dx.com/proteomics-protein-research/intervenn-shifts-direction-again-immunotherapy-focus-cancer-screening#.Y9eGJOxBydY